NASDAQ: CLRB
Cellectar Biosciences Inc Stock Ownership - Who owns Cellectar Biosciences?

Insider buying vs selling

Have Cellectar Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James V. CarusoChief Executive Officer2026-05-078,680$2.88
$25.00kBuy
Jarrod LongcorChief Operating Officer2026-05-078,680$2.88
$25.00kBuy
John NeisDirector2025-12-12198$3.70
$732.01Sell

1 of 1

CLRB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLRB insiders and whales buy or sell their stock.

CLRB Shareholders

What type of owners hold Cellectar Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Austin W. Greenhouse David M. Marxe12.09%1,142,368$2.68MInsider
Cormorant Asset Management LP5.61%530,000$1.25MInsider
Alumni Research Foundation Wisconsin4.97%469,484$1.10MInsider
John Neis3.85%363,725$854.75kInsider
Richard Hertzberg2.96%280,000$658.00kInsider
Jamey P. Weichert2.49%235,336$553.04kInsider
Paul L. Berns1.24%117,371$275.82kInsider
Andrei Shustov0.58%55,037$129.34kInsider
Darrell Shane Lea0.42%39,599$93.06kInsider
Douglas J. Swirsky0.26%25,000$58.75kInsider

1 of 3

CLRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLRB0.03%35.70%Net Buying
TCRX0.05%25.11%Net Buying
KRSA0.02%99.98%Net BuyingNet Buying
ESLA0.01%68.68%Net BuyingNet Buying
COCP0.00%100.00%Net BuyingNet Buying

Cellectar Biosciences Stock Ownership FAQ

Who owns Cellectar Biosciences?

Cellectar Biosciences (NASDAQ: CLRB) is owned by 0.03% institutional shareholders, 35.70% Cellectar Biosciences insiders, and 64.27% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cellectar Biosciences shareholder, owning 1.14M shares representing 12.09% of the company. Austin W. Greenhouse David M. Marxe's Cellectar Biosciences shares are currently valued at $2.74M.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.